1-5 of 5
Animesh Pardanani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape

Ayalew Tefferi, Naseema Gangat, Animesh Pardanani, John D. Crispino
Journal: Cancer Research
Cancer Res (2022) 82 (5): 749–763.
https://doi.org/10.1158/0008-5472.CAN-21-2930
Published: 03 March 2022
View article titled, Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape
Open the PDF for Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape in another window
Journal Articles

Abstract LB-294: Determination of JAK2V617F allele burden in a phase II study of patients with myelofibrosis treated with SAR302503 using a sensitive and robust allele-specific qPCR assay.

Feng Liu, Moshe Talpaz, Animesh Pardanani, Catriona Jamieson, Nashat Gabrail, Ayalew Tefferi, Tianlei Lei, Rita Greco, Francisco Adrian, Nikki Daskalakis, Claudia Lebedinsky, Pamela Cohen, Donald Bergstrom
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): LB-294.
https://doi.org/10.1158/1538-7445.AM2013-LB-294
Published: 15 April 2013
View article titled, Abstract LB-294: Determination of <em>JAK2</em>V617F allele burden in a phase II study of patients with myelofibrosis treated with SAR302503 using a sensitive and robust allele-specific qPCR assay.
Journal Articles

Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms

Sangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, Yiting Yu, Li Zhou, Tushar D. Bhagat, Davendra Sohal, Britta Will, Yongkai Mo, Masako Suzuki, Animesh Pardanani, Michael McDevitt, Jaroslaw P. Maciejewski, Ari M. Melnick, John M. Greally, Ulrich Steidl, Alison Moliterno, Amit Verma
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1076–1085.
https://doi.org/10.1158/0008-5472.CAN-12-0735
Published: 31 January 2013
View article titled, Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms
Open the PDF for Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms in another window
Includes: Supplementary data
Journal Articles

Abstract DDT01-03: Discovery of BMS-911543, a highly selective JAK2 inhibitor, as a clinical candidate for the treatment of myeloproliferative disease and other malignancies

Ashok V. Purandare, Honghe Wan, Gretchen Schroeder, Amy Hart, James Grebinski, Jennifer Inghrim, John Tokarski, Dan You, Becky Penhallow, Theresa McDevitt, Ragini Vuppugalla, Yueping Zhang, Stefan Ruepp, George Trainor, Xia Han, Louis Lombardo, Francis Y. Lee, Marco Gottardis, Jennifer Hosbach, Elizabeth Fitzpatrick, Stuart Emanuel, Animesh Pardanani, Terra L. Lasho, Ayalew Tefferi, Matthew V. Lorenzi
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): DDT01-03.
https://doi.org/10.1158/1538-7445.AM2011-DDT01-03
Published: 15 April 2011
View article titled, Abstract DDT01-03: Discovery of BMS-911543, a highly selective JAK2 inhibitor, as a clinical candidate for the treatment of myeloproliferative disease and other malignancies
Journal Articles

A novel Jak2 inhibitor for the treatment of myeloproliferative disorders

Andrew Wilks, Christopher Burns, Gregg Smith, Emmanuelle Fantino, Ian Phillips, Michelle McNally, David Bourke, Laura Andrau, Naomi Court, Patricia Bukczynska, Max Joffe, Ayalew Tefferi, Animesh Pardanani, Terra Lasho, Will Stevenson, Osvaldo Cooley, Andrew Roberts, Elizabeth OFlaherty, Thomas Bumm, Jutta Deininger, Jeffrey Tyner, Michael Deininger
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 4880.
Published: 01 May 2008
View article titled, A novel Jak2 inhibitor for the treatment of myeloproliferative disorders